Access Consortium statement on COVID-19 vaccines evidence

The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post-market pharmacovigilance. This collective statement on COVID-19 vaccines builds on the Consortium's May 2020 pledge to work together to counter the COVID-19 global pandemic.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 17:44 (UTC)
Created April 17, 2026, 17:44 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2021-01-21 00:00:00
open_canada_keywords {"fr": ["coronavirus", "COVID-19", "vaccins", "international", "médicaments", "médicaments", "produits biologiques", "Santé Canada"], "en": ["coronavirus", "COVID-19", "vaccines", "international", "medications", "drugs", "biologics", "Health Canada"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Déclaration du Consortium Access sur les preuves relatives aux vaccins contre la COVID-19
update_frequency as_needed